Juana Gonzalez Selected Research

Juana Gonzalez Research Topics

Disease

13	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2009
9	Atopic Dermatitis (Atopic Eczema) 11/2021 - 06/2014
6	Neoplasms (Cancer) 01/2017 - 06/2012
5	Inflammation (Inflammations) 01/2023 - 06/2014
4	Skin Diseases (Skin Disease) 05/2024 - 12/2013
3	Hidradenitis Suppurativa 05/2024 - 01/2021
3	Hyperplasia 01/2019 - 06/2014
2	Mycosis Fungoides 01/2017 - 09/2014
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2010 - 08/2006
2	Hyperprolactinemia 06/2009 - 08/2006
1	Alopecia Areata 11/2018
1	Heart Failure 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Ureteral Obstruction 09/2017
1	Atherosclerosis 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Disease Progression 09/2014
1	Melanoma (Melanoma, Malignant) 12/2013
1	Basal Cell Carcinoma (Rodent Ulcer) 12/2013
1	Actinic Keratosis 02/2013
1	Starvation 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 06/2009

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 11/2021 - 01/2009
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2014
5	Interleukin-17 (Interleukin 17)IBA 01/2023 - 12/2013
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2014
4	Messenger RNA (mRNA)IBA 01/2021 - 09/2014
3	Interleukin-22 (IL-22)IBA 01/2019 - 01/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 06/2014
2	RNA (Ribonucleic Acid)IBA 01/2023 - 05/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2006
2	Keratin-16 (Keratin 16)IBA 01/2019 - 01/2017
2	AntigensIBA 11/2017 - 07/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 12/2013
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	pneumococcal purpura-producing principle (PPPP)IBA 01/2023
1	4-nitrophenyl phenylphosphonateIBA 01/2023
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	Ustekinumab (CNTO 1275)FDA Link 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	InterleukinsIBA 01/2022
1	brodalumabIBA 01/2022
1	ProteomeIBA 01/2021
1	Cathepsin DIBA 01/2021
1	Filaggrin ProteinsIBA 01/2019
1	fezakinumabIBA 01/2019
1	loricrinIBA 01/2019
1	AutoantigensIBA 11/2017
1	ThrombospondinsIBA 11/2017
1	DisintegrinsIBA 11/2017
1	LipidsIBA 11/2017
1	Metalloproteases (Metalloproteinases)IBA 11/2017
1	Phospholipases A2 (Phospholipase A2)IBA 11/2017
1	CathelicidinsIBA 11/2017
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Adalimumab (Humira)FDA Link 01/2017
1	Macrophage Colony-Stimulating FactorIBA 01/2017
1	CD40 Ligand (CD40L)IBA 01/2017
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2017
1	Chemokine CX3CL1IBA 01/2017
1	6-sulfo sialyl Lewis XIBA 10/2015
1	ElafinIBA 06/2014
1	Interleukin-13IBA 06/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 06/2014
1	Interleukin-8 (Interleukin 8)IBA 12/2013
1	MitogensIBA 12/2013
1	Anaplastic Lymphoma KinaseIBA 12/2013
1	interleukin-22 receptor (IL-22R)IBA 01/2013
1	Estrogens (Estrogen)FDA Link 08/2010
1	Selective Estrogen Receptor Modulators (SERM)IBA 08/2010
1	CalciumIBA 06/2009
1	Gonadal Steroid Hormones (Sex Hormones)IBA 06/2009
1	ProlactinIBA 08/2006

Therapy/Procedure

2	Therapeutics 11/2017 - 12/2013
1	Aftercare (After-Treatment) 01/2022
1	Heart-Assist Devices 01/2018
1	Lasers (Laser) 02/2013
1	Immunotherapy 06/2012